Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OneUP DNA is a Seattle-based veterinary biotech company focused on molecular biology testing and drug development for canine oncology. The company currently offers specialized molecular tests to veterinary oncologists, with a particular emphasis on blood cancers and dog leukocyte antigen typing to support donor-recipient matching in canine bone marrow transplantation. It also states that it aims to develop canine-specific cancer drugs, indicating an early-stage therapeutics effort alongside its diagnostics business. The team highlights scientific expertise from leading cancer research institutions, including Fred Hutchinson Cancer Center. Overall, OneUP DNA appears to be an early-stage, private veterinary life science company operating at the intersection of molecular diagnostics and translational oncology for dogs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OneUP DNA.